Motif-based SARS-CoV-2 protein-human protein interactions as potential antiviral target sites

Australia News News

Motif-based SARS-CoV-2 protein-human protein interactions as potential antiviral target sites
Australia Latest News,Australia Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 53 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 71%

Motif-based SARS-CoV-2 protein-human protein interactions as potential antiviral target sites biorxivpreprint uppsalauni SARSCoV2 COVID19 Antiviral AntiviralTarget

By Pooja Toshniwal PahariaOct 13 2022Reviewed by Aimee Molineux In a recent study posted to the bioRxiv* preprint server, researchers performed a ProP-PD analysis to identify peptides from intrinsically disordered human proteome regions that bind with severe acute respiratory syndrome coronavirus 2 genome-encoded folded protein domains .

PD expression constructs were created from SARS-CoV-2 proteins , of which 26 PDs were used for ProP-PD phage display selection screen analysis against the human disorderome peptide library. The HD2 library displayed amino acid overlapping peptides in the host proteome’s disordered sites on the M13 phage surface.

Results Eleven folded PDs of the SARS-CoV-2 genome were bound to human genome peptides. Out of 281 high/medium peptides, 239 host proteins were found to interact with SARS-CoV-2 PDs including Nsp1,3,5,8,9, and 16, Ubl1, adipocyte differentiation-related protein , SUD-M, open reading frame -8, 9b and nucleocapsid protein N-terminal domain .

The FP analysis of 23 peptide-peptide interactions involving eight SARS-CoV-2 PDs showed binding affinities in the micromolar range. The leucine residues at P1 , with tyrosine residues at P5, were essential for binding, indicating that the Nsp3 Ubl1 binding motif in NCOA21074-1089 was LxxxY. Enrichment of ligands associated with transcriptional regulation processes was observed.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Leah 'remains' found where paedo lived 3 years after cops knocked on doorLeah 'remains' found where paedo lived 3 years after cops knocked on doorHUMAN remains thought to be those of missing Leah Croucher were discovered by cleaners at an empty house where a paedophile once lived, it is claimed. Cops had knocked on the door of the empty prop…
Read more »

Researchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteinsResearchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteinsIn a new study, researchers pursued direct-acting severe acute respiratory syndrome coronavirus-2 drugs that compete for nucleotide-binding pockets (NBPs) of SARS-CoV-2 proteins.
Read more »

Immune-mediated inflammatory diseases following COVID-19Immune-mediated inflammatory diseases following COVID-19Immune-mediated inflammatory diseases following COVID-19 medrxivpreprint unibirmingham COVID19 SARSCoV2 InflammatoryDisease
Read more »

What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?A new review commented on a previous study regarding the real-world effectiveness of oral antivirals against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.
Read more »

A novel molecularly imprinted polypyrrole electrode for diagnosing COVID-19A novel molecularly imprinted polypyrrole electrode for diagnosing COVID-19A recent study examines the interaction between the SARS-CoV-2 spike glycoprotein through the use of a molecularly imprinted polypyrrole electrode.
Read more »

The ability of antiviral formulation ViruSAL to inhibit SARS-CoV-2 infectivityThe ability of antiviral formulation ViruSAL to inhibit SARS-CoV-2 infectivityResearchers from Ireland used human bronchial epithelium models to evaluate the ability of a novel proprietary formulation called ViruSAL to inhibit SARS-CoV-2 infections.
Read more »



Render Time: 2025-03-27 04:12:00